CRISPR Medicine

Biomedrex Genetics

Main focus: Next-generation CRISPR-based antiviral therapies

Company stage: Pre-clinical

Diseases (gene editing): HIV-1, influenza, SARS-CoV-2

Genome editing tool: CRISPR

Funding stage: Private

Location: Huddinge, Sweden

Website: https://www.biomedrex.com/index.html


Biomedrex Genetics is a start-up company that develops novel antiviral treatments based on the CRISPR-Cas system. The company aims to treat various infectious diseases, with HIV-1 being the lead viral target. The company is currently conducting pre-clinical testing.

See the full view ...